• Product NameNOC2L Antibody
• Host SpeciesRabbit
• ClonalityPolyclonal
• PurificationThe antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
• ApplicationsWB IHC
• Species ReactivityHu
• SpecificityThe antibody detects endogenous levels of total NOC2L protein.
• Immunogen TypePeptide
• Immunogen DescriptionThe antiserum was produced against synthesized peptide derived from human NOC2L.
• Target NameNOC2L
• Alternative Names    NIR; NET7; NET15
• Accession No. Swiss-Prot#: Q9Y3T9
  NCBI Gene ID: 26155
  Gene Accssion: BC003555/Q9Y3T9
• UniprotQ9Y3T9
• Gene ID26155;
• SDS-PAGE MW 85kd
• Concentration 1.0 mg/ml
• Formulation Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
• Storage Store at -20˚C

• WB 1:500-1:2000
  IHC 1:100-1:300
  

Histone modification by histone acetyltransferases (HAT) and histone deacetylases (HDAC) can control major aspects of transcriptional regulation. NOC2L represents a novel HDAC-independent inhibitor of histone acetyltransferase (INHAT)?

• Immunohistochemical analysis of paraffin-embedded Human prostate cancer tissue using #36655 at dilution 1/20.
• Western blot analysis of lysates from MCF-7 cells, using NOC2L Antibody. The lane on the right is blocked with the synthesized peptide.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting